Global Over-the-Counter (OTC) Drug Markets

 
   Single User - $3,995
   Site License (one location, 10 users) - $5,995
   Corporate License - $7,990



Loading...
Published Jan 23, 2018 | 171 Pages | Pub ID: KLI15581138

Global Over-the-Counter (OTC) Drug Markets

The global over-the-counter (OTC) drug market is highly fragmented by region. This is largely due to differences in economic conditions, perception of self-medication, education, access to medical advice and products, demographics, product availability, and incidence of diseases and medical conditions. Global Over-the-Counter (OTC) Drug Markets discusses the global and regional OTC markets, including market data on the following:
  • Global Over-the-Counter Drug Market Analysis: 2017 to 2023
  • Top Twenty OTC Drug Markets, Country Market Share (%), 2017 (United States, Japan, China, Germany, France, India, Brazil, Russia, United Kingdom, Australia, Mexico, Canada, Italy, Spain, Poland, Turkey, Argentina, Venezuela, South Africa, Saudi Arabia, Rest of World)
  • Total Pharmaceutical Markets: Prescription vs. Non-Prescription by Country, 2017 (% of total pharmaceutical market) (United States, Japan, China, Germany, France, India, Brazil, Russia, United Kingdom, Australia, Mexico, Canada, Italy, Spain, Poland, Turkey, Argentina, Venezuela, South Africa, Saudi Arabia)
  • Global OTC Drug Market Analysis, Markets by Product Segment, 2017 to 2023 (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other, Total)
  • OTC Drug Markets in Asia Pacific
  • OTC Drug Markets in Europe
  • OTC Drug Markets in Latin America
  • OTC Drug Markets in Middle East & Africa
  • OTC Drug Markets in North America
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. By definition, the FDA has found them to be safe for use without medical supervision. As the pharmaceutical industry has grown, patients have become more involved in health-care issues and now have taken some medical treatment into their own hands. This has provided an opportunity for pharmaceutical companies to invest in research and development of OTC drugs. Drugs included in OTC segments are pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product. For the purpose of this study, Kalorama Information divides and discusses OTC product markets in five general segments:
  • OTC Central Nervous System Agents (Analgesics, Anti-Inflammatories, and Other Central Nervous System Agents)
  • OTC Dermatological Agents (Acne Treatments, Antifungals/Antiinfectives, Hair Growth Remedies, Others)
  • OTC Gastrointestinal System Agents (Laxatives, Antacids, Antidiarrheals, H2 Antagonists, Proton Pump Inhibitors)
  • OTC Respiratory System Agents (Antihistamines, Decongestants, Cough Preparations, Other Respiratory Agents)
  • OTC Agents -- Various Therapeutic Classifications (Smoking Cessation Market, Contraceptive Drugs, Weight Management Drugs [OTC drugs, not dietary supplements], Overactive Bladder Treatments)
The regional coverage in Global OTC Drug Markets goes to the country level in North America, Asia Pacific, Europe, Latin America, Middle East & Africa, including the following:
  • North America OTC Drug Market Value by Country, 2017 and 2023 (Canada, United States, Rest of North America)
  • OTC Drug Markets in the United States by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in Canada by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • Asia Pacific OTC Drug Market Value by Country, 2017 and 2023 (Australia, China, India, Japan, Rest of Asia Pacific)
  • OTC Drug Markets in Japan by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in China by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in India by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in Australia by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • Europe OTC Drug Market Value by Country, 2017 and 2023 (France, Germany, Italy, Poland, Russia, Spain, Turkey, United Kingdom)
  • OTC Drug Markets in Germany by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in France by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets In Russia by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in The United Kingdom by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in Italy by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in Spain by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in Poland by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in Turkey by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • Latin America OTC Drug Market Value by Country, 2017 and 2023 (Argentina, Brazil, Mexico, Venezuela, Rest of Latin America)
  • OTC Drug Markets in Brazil by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in Mexico by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in Argentina by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in Venezuela by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • Middle East & Africa OTC Drug Market Value by Country, 2017 and 2023 (Saudi Arabia, South Africa, Rest of Middle East & Africa)
  • OTC Drug Markets in South Africa by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • OTC Drug Markets in Saudi Arabia by Therapeutic Class, 2017 (%) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
  • Middle East & Africa OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers’ level) (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other, Total)
  • Middle East & Africa OTC Drug Market by Therapeutic Class, 2017 and 2023 (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other)
The consumer healthcare market involves a range of large and small competitors. Although hundreds of companies compete in the world OTC drug market, a handful of companies secure leading positions. Many leading companies are taking advantage of new opportunities in developing regions, which is adding to the competitive landscape of the OTC market. Global OTC Drug Markets notes the leading suppliers’ shares of the OTC drug market by revenues for 2017 and also includes in-depth profiles for the following companies:
  • Bayer
  • GlaxoSmithKline
  • Johnson & Johnson
  • Mylan
  • Perrigo Co.
  • Pfizer
  • Procter & Gamble
  • Reckitt Benckiser
  • Sanofi
  • Taisho Pharmaceutical
The report includes discussions of conditions often treated with OTC medicines, health statistics related to the industry, global populations, aging populations, populations by region and issues affecting the market as a whole. Information is presented as a global overview, with special emphasis on primary markets such as the United States, Japan, China, Germany, and other key markets. The market segments provide an overview of demographics, market estimates and market forecasts.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the global market at the manufacturers’ level. The base year for data is 2017. Forecast data is provided through 2023. Competitive analysis is provided for the year 2017. The forecasted market analysis for 2017-2023 was largely based on impact of industry consolidation, demographic trends, new developments, and global expansion.
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.